The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The FDA announced it is seeking public comment on a potential change that would require opioid analgesics used in outpatient settings to be dispensed ...
read more
Zambon announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to colistimethate sodium powder for ...
read more
Wednesday, April 20, 2022
Dragonfly Therapeutics, Inc. announced an expansion of its research collaboration with AbbVie to discover and develop Dragonfly's novel ...
read more
Wednesday, April 20, 2022
Arcturus Therapeutics Holdings Inc. announced topline data from an ongoing Phase 1/2/3 trial evaluating ARCT-154, Arcturus’ self-amplifying mRNA ...
read more
Wednesday, April 20, 2022
Merck announced that Joseph Romanelli will lead Human Health International, and join Merck’s Executive Team, effective August 1, 2022.
read more
Takeda has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular ...
read more
AstraZeneca and Daiichi Sankyo received notification of acceptance of the supplemental Biologics License Application (sBLA) of Enhertu (trastuzumab ...
read more
Hansa Biopharma AB, “announced the acceptance by the U.S. FDA of Hansa’s Investigational New Drug (IND) application to proceed with a Phase 3 study of...
read more
Agilent Technologies Inc. has joined the National Institute for Innovation in Manufacturing to Advance Biomanufacturing (NIIMBL). Membership in NIIMBL...
read more
Health Canada authorized Evusheld (tixagevimab and cilgavimab) for the prevention of COVID-19. After a thorough and independent scientific review of ...
read more
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that detects chemical ...
read more
Nektar Therapeutics and Bristol Myers Squibb announced that based on results from pre-planned analyses of two late-stage clinical studies of ...
read more
Merck announced that Health Canada has granted approval for KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, as a treatment for adult patients ...
read more
Valneva SE announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted Conditional Marketing ...
read more
Merck announced that V116, the company’s investigational 21-valent pneumococcal conjugate vaccine, has received Breakthrough Therapy Designation from ...
read more